[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Summit Therapeutics Inc. Common Stock (SMMT)
Summit Therapeutics Inc. (SMMT) is trading near its 52-week low, with recent positive trial data and insider buying overshadowing trial design concerns. Analysts suggest it could be a stock to watch.
About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc. Common Stock (SMMT) is a publicly traded stock in the healthcare sector.
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the Stocks category.
Insights
- Summit Therapeutics Inc. Common Stock (SMMT) market dominance near a 52-week low at XXXXXXX.
- Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) mentions is up XXXXX% from the previous week.
- Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXX% from the previous week.
Price: $XX
Price 24-Hour Time-Series Raw Data
The recent 7-day price increase for SMMT is attributed to positive trial data and insider buying, which are currently overshadowing concerns about trial design.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-04-24
1-Year Low: $XXXXX on 2025-11-21
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #935 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XX
X Month: XXX -XX
X Months: XXX +121
X Year: XXX +269
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-02-09
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX +7
X Year: XX -XX
1-Year High: XX on 2025-04-22
1-Year Low: X on 2025-03-18
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-12-06
Engagements by network (24h): News: XX Reddit: XX X: XXXXX YouTube: X
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +12%
X Month: XXX -XX%
X Months: XXXXX +7%
X Year: XXXXXX +30%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-12-02
Mentions by network (24h): News: X Reddit: XX X: XXX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XXX
X Week: XXX +4.40%
X Month: XXX -XX%
X Months: XXXXX +56%
X Year: XXXXX +71%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-12-06
The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ICC_Andy | X | XXX | X | XXX |
| @ParadiseTraderr | X | XXX | X | XXX |
| @BuyTheUgly | X | XX | XX | XXX |
| @ExBridgewater | X | XXX | X | XXX |
| @POWERLONG8 | X | XX | X | XXX |
| @TRDRZone | X | XXX | X | XX |
| @mariostario2019 | X | XX | X | XX |
| @JacobPlieth | X | XXXXXX | X | XX |
| @FrenzyCapital | X | XXXXX | X | XX |
| @MiriamF24887120 | XX | XX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -X%
X Year: XX% -XX%
1-Year High: XXX% on 2025-10-07
1-Year Low: XX% on 2025-03-23
Most Supportive Themes:
- Insider Buying: (30%) Executives are actively purchasing shares, indicating strong confidence in the company's future prospects.
- Phase III Development Expansion: (25%) The expansion of the global Phase III development program for Ivonescimab suggests positive progress and potential for future drug approvals.
- Potential AstraZeneca Partnership: (20%) Anticipation of a partnership with AstraZeneca is driving bullish sentiment and investor interest.
Most Critical Themes:
- Trial Design Concerns: (15%) There are underlying concerns regarding the trial design and potential FDA approval, which could pose risks.
- Market Skepticism: (10%) Despite positive news, there is market skepticism about the company's turnaround narrative and execution risks.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.034%
X Month: XXXXX% +0.0021%
X Months: XXXXX% -XXXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-04-25
1-Year Low: XXXXXX% on 2025-10-07
Market Dominance: XXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-11-21
Market Cap: $XXXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$4.10%
X Month: $XXXXXXXXXXXXXX -$6%
X Months: $XXXXXXXXXXXXXX -$8.70%
X Year: $XXXXXXXXXXXXXX -$3.10%
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24
1-Year Low: $XXXXXXXXXXXXXX on 2025-11-21
Top Summit Therapeutics Inc. Common Stock News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Trading Near Its 52-Week Low Is Summit Therapeutics a Good Stock to Buy Right Now The Motley Fool"
News Link @themotleyfool 2025-12-06T21:51Z 228.6M followers, XXX engagements
"Summit Therapeutics Inc. (SMMT): Among the Stocks That Will Go to the Moon According to Analysts"
News Link @YahooFinance 2025-04-09T16:16Z 228.6M followers, 112.6K engagements
Top Summit Therapeutics Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Buy Signal Summit Therapeutics Inc - XX Dec 2025 @ 12:30 - USD17.98"
Reddit Link @jvc72 2025-12-11T17:36Z X followers, X engagements
"$SMMT 🙋♂ Guys Don't miss the next move in a few hours. 📊"
X Link @UtterP42232 2025-12-11T05:41Z XX followers, XX engagements
"$TIL $SMMT #immuneonco The global CD47-SIRP(alpha ) inhibitors market size in 2024 stands at approximately $XXXX billion USD"
X Link @POWERLONG8 2025-12-10T21:28Z XX followers, XX engagements
"$TIL $BNTX $SMMT #immuneonco Adding enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) to the PD-L1 VEGF and CD47 combination therapy significantly augments the anti-tumor response by adding a powerful direct tumor-killing mechanism via the innate immune system. This creates a more comprehensive and robust approach to cancer treatment"
X Link @POWERLONG8 2025-12-10T19:06Z XX followers, XXX engagements